NCT06806423

Brief Summary

This study evaluates the clinical and radiographic outcomes of topical vitamin D application on immediate dental implants in patients undergoing single-rooted tooth extraction in the anterior mandibular region.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 4, 2025

Completed
Last Updated

February 11, 2025

Status Verified

February 1, 2025

Enrollment Period

1.2 years

First QC Date

January 28, 2025

Last Update Submit

February 7, 2025

Conditions

Keywords

Immediate dental implantsCalcitriol1,25-dihydroxycholecalciferolOsseointegrationImplant stabilityBone densityIDRISI Kilimanjaro software

Outcome Measures

Primary Outcomes (2)

  • Implant Stability (ISQ)

    Implant stability was measured using the Osstell ISQ device, providing precise, non-invasive, and objective assessments for monitoring osseointegration. A SmartPeg was securely attached to the implant, and a probe connected to the device was positioned at a right angle toward the implant. The Implant Stability Quotient (ISQ) was measured on a scale from 1 to 100, with values above 70 indicating high stability, 60-69 indicating medium stability, and values below 60 suggesting low stability. Stability was assessed immediately after surgery and then reassessed at 3 and 6 months.

    Baseline, 3, and 6 months postoperatively

  • Bone Density

    Radiographic evaluations were conducted using direct digital periapical radiographs, captured with the KaVo Scan eXam™ One system and Rinn XCP device. Radiographs were taken immediately postoperatively, and at 3 and 6 months. Bone density around the implants was analyzed using IDRISI Kilimanjaro software, which measured grayscale values to quantify density. Bone density was quantified on a 255-point grayscale, with 0 representing black regions and 255 representing white regions. Two zones were assessed: the osseointegration zone adjacent to the implant and the surrounding bone. This approach provided precise monitoring of bone density changes over time.

    Baseline, 3 and 6 months postoperatively

Secondary Outcomes (3)

  • Peri-implant Probing Depth (PD)

    3 and 6 months postoperatively

  • Bleeding Index (BI)

    3 and 6 months postoperatively

  • Visual Analogue Scale for Pain (VAS)

    Days 1, 3, and 7 postoperatively

Study Arms (2)

Control Group

ACTIVE COMPARATOR

12 implants were placed immediately after teeth extraction.

Procedure: Immediate Dental Implant Placement without Adjunctive Treatments

Vitamin D Group

EXPERIMENTAL

12 implants were placed immediately after teeth extraction, combined with topical vitamin D gel application.

Procedure: Immediate Dental Implant Placement with Topical Vitamin D Gel Application

Interventions

Atraumatic extractions using periotomes and anterior forceps. Osteotomy was prepared with a standardized drilling sequence under copious irrigation. ROOTT R-line implants were selected based on socket dimensions. No topical vitamin D3 was applied. Implants were placed into fresh extraction sockets.

Control Group

The same procedure as the control group, with the addition of sterile topical vitamin D3 (calcitriol) gel applied to both the implant surface and osteotomy site immediately before implant placement.

Vitamin D Group

Eligibility Criteria

Age21 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Both genders.
  • Middle-aged adults (from 21 years to 40 years).
  • Healthy American Society of Anesthesiologists patients (ASA I).
  • Patients with teeth or roots indicated for extraction at the lower anterior region.

You may not qualify if:

  • Pregnant or lactating females.
  • Patients with parafunctional or bad oral habits such as bruxism or smoking (more than 10 cigarettes per day).
  • Patients with bad oral hygiene.
  • Patients with severe periodontal diseases (severe vertical or horizontal bone loss).
  • Pathological changes or infections related to teeth indicated for immediate implant placement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral & Maxillofacial Surgery Department, Faculty of Dentistry, Suez Canal University

Ismailia, Ismailia Governorate, 41522, Egypt

Location

Study Officials

  • Bassem M. Ayyad

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Bassem M. Ayyad

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 4, 2025

Study Start

October 11, 2022

Primary Completion

January 1, 2024

Study Completion

October 1, 2024

Last Updated

February 11, 2025

Record last verified: 2025-02

Locations